Infliximab in inflammatory bowel disease: attention to adverse events

Tarih
2014
Yazar
Demir, K.
Besisik, F.
Aydogan, T.
Kaymakoglu, S.
Baran, B.
Uyanikoglu, A.
Ermis, F.
Akyuz, F.
Pinarbasi, B.
Üst veri
Tüm öğe kaydını göster
Özet
OBJECTIVE: To assess the efficacy and adverse effects of infliximab in patients with Crohn's disease and ulcerative colitis who are resistant to conventional therapy or having fistulising type Crohn's disease.
Bağlantı
http://hdl.handle.net/20.500.12627/39053
Koleksiyonlar